ASCO Breakthrough is an annual Asia-Pacific oncology meeting that brings together global experts to share novel research and multidisciplinary perspectives on the latest scientific discoveries, clinical advances, and emerging treatment approaches transforming cancer care. This year, ASCO Breakthrough 2026 is bringing together the global oncology community in Singapore and online from June 25–27 for three days of high-impact scientific and educational sessions, case-based discussions, and abstract presentations, fostering collaboration and knowledge exchange to advance cancer care worldwide.
Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shares key insights and highlights from ASCO Breakthrough 2026:
Outstanding presentation by Dr. Francesca Lim
“Outstanding presentation by Dr. Francesca Lim at the 2026 ASCO Breakthrough Annual Meeting highlighting the latest advances in CAR T-cell therapy and the opportunities that lie ahead.
Dr. Lim delivered an excellent overview of the remarkable progress CAR T-cell therapy has made while thoughtfully addressing the significant challenges that remain—particularly in T-cell lymphomas, where unique biologic and manufacturing hurdles continue to drive innovation. Her discussion provided valuable perspective on where the field stands today and the exciting directions that may shape its future.
A fantastic presentation filled with insightful discussion from a leader helping advance the next generation of cellular therapies.”
ADCs in Lung Cancer Dr David R Gandara ASCO Breakthrough 2026
“Outstanding “Tour de France” through the evolving landscape of antibody-drug conjugates (ADCs) in lung cancer by Dr. David R. Gandara at the 2026 ASCO Breakthrough Annual Meeting.
From the rapid evolution of ADCs to where the field is headed next, Dr. Gandara delivered an exceptional overview of one of the most exciting areas in thoracic oncology. The audience greatly appreciated his thoughtful commentary, clinical insights, and vision for the future.
Privileged to learn from a true global leader who continues to help shape the future of lung cancer care.”
Global ADC Ecosystem Dr Lillian L Siu ASCO Breakthrough 2026
“An outstanding presentation on the global antibody-drug conjugate (ADC) ecosystem by Dr. Lillian L. Siu at the 2026 ASCO Breakthrough Annual Meeting.
Dr. Siu provided a comprehensive perspective on the rapidly expanding ADC landscape—from scientific innovation and clinical development to the collaborative ecosystem driving the next generation of targeted therapies. Her insights highlighted both the remarkable progress achieved and the exciting opportunities that lie ahead across tumor types.
A privilege to learn from one of oncology’s foremost leaders whose vision continues to shape the future of precision cancer therapeutics.”
Immunotherapy in Colorectal Cancer: Dr Gwo Fuang Ho ASCO Breakthrough 2026
“Eloquent review of the latest promising targeted immunotherapy clinical trials for colorectal cancer by Dr Gwo Fuang Ho at 2026 ASCO Breakthrough Annual.”
Cancer Incidence in Asia and ctDNA Dr Herbert Loong ASCO Breakthrough 2026
“Great overview of incidence of cancers within Asia as well at the latest developments in ctDNA and early diagnostics from Dr Herbert Loong at ASCO Breakthrough.”
DLBCL Treatment Landscape: Dr Bor-Sheng Ko ASCO Breakthrough 2026
“One of the highlights of the meeting was Dr. Bor-Sheng Ko‘s outstanding session on the rapidly evolving treatment landscape for diffuse large B-cell lymphoma (DLBCL) at the 2026 ASCO Breakthrough Annual Meeting.
Dr. Ko seamlessly connected today’s evidence-based practice with tomorrow’s innovations, providing a clear roadmap of where DLBCL management is headed. From advances in immunotherapy and cellular therapy to emerging targeted strategies, the session captured both the progress already achieved and the exciting possibilities on the horizon.
An engaging and insightful presentation that left the audience with a deeper appreciation of how innovation is continuing to redefine lymphoma care.”
Confronting the Global Surge of Early-Onset Cancers
“An insightful session hosted by Dr Kimmie Ng about Young and Diagnosed: Confronting the Global Surge of Early-Onset Cancers filled with great speakers, insight and approaches to combat global inequities at the 2026 ASCO Breakthrough Meeting.”
Honoring Dr. Julie Gralow’s Lasting Impact on Global Oncology
“Congratulations to Dr. Julie Gralow on receiving the MedNews Week Global Oncology Leadership Award at ASCO Breakthrough 2026.
Some leaders are remembered for the discoveries they make. The truly extraordinary ones are remembered for the people they inspire.
Dr. Gralow has dedicated her career not only to advancing the field of oncology, but also to uplifting those who will shape its future. Through her unwavering commitment to global cancer care, education, mentorship, and equity, she has selflessly invested in the next generation of physicians, researchers, and healthcare professionals around the world.
Her leadership is matched only by her kindness. She leads with humility, serves with compassion, and gives generously of her time to help others succeed. Countless careers have been influenced by her encouragement, guidance, and belief in the potential of young investigators. She is a pioneer, a global mentor, and a role model whose impact extends far beyond any one institution or country.
It is our great privilege at MedNews Week to recognize Dr. Gralow for her extraordinary leadership and lifelong commitment to empowering others. The oncology community is stronger because of her vision, and the next generation is brighter because she has chosen to invest in it.
Congratulations, Dr. Gralow, and thank you for being the kind of leader our field is fortunate to have. Your heart of gold, dedication to service, and passion for mentoring continue to inspire meaningful change across the globe.”
Honoring Dr. Melvin L.K. Chua: A Legacy of Mentorship and Global Oncology Leadership
“Congratulations to Dr. Melvin L.K. Chua on receiving the MedNews Week Excellence in Mentorship Award at ASCO Breakthrough 2026.
Some of the greatest contributions to oncology are not measured solely by publications or discoveries, but by the people we inspire, mentor, and empower. Dr. Chua embodies that spirit every day.
Through his unwavering commitment to trainee mentorship, global oncology education, and international collaboration, he has helped shape the careers of countless young physicians and scientists while advancing cancer care across borders. His generosity with his time, knowledge, and encouragement has left a lasting impact on the next generation of oncology leaders.
It is our great privilege at MedNews Week to recognize Dr. Chua’s extraordinary dedication to mentorship and service. He is not only an outstanding physician-scientist, but also a role model whose humility, vision, and commitment to others continue to inspire us all.
Congratulations, Dr. Chua, and thank you for everything you do for the global oncology community. Your impact extends far beyond the patients you care for—it lives on through every trainee, collaborator, and future leader you have helped along the way.”
Behind the Scenes of ASCO Breakthrough 2026
“One of the greatest lessons from ASCO Breakthrough 2026 is that the success of a conference isn’t defined only by what happens on stage-it’s made possible by the countless individuals working tirelessly behind the scenes.
To the incredible ASCO staff, thank you. While many attendees see the sessions, speakers, and scientific breakthroughs, few get to witness the dedication, planning, and long hours that make an event of this caliber possible. You are the silent warriors whose commitment creates an environment where collaboration, education, and innovation can flourish.
I know I wasn’t able to meet everyone personally, but please know that your hard work does not go unnoticed. Thank you for your professionalism, warmth, and unwavering commitment to advancing oncology through world-class meetings.
And to Dr. Julie Gralow, thank you for your exceptional leadership. Great organizations reflect the people who lead them, and your vision, humility, and commitment to serving the global oncology community are evident throughout this meeting. Your leadership continues to inspire all of us, and the field is stronger because of it.
To everyone who helped bring ASCOBT26 to life-thank you for an unforgettable experience.”
Stay tuned with OncoDaily for more updates from ASCO Breakthrough 2026.
